Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00240643 | Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke | PHASE2 | COMPLETED | 640 | — | — | Nov 1, 2005 | Dec 1, 2006 | Jan 16, 2017 | 116 | United States, Argentina +23 |
| Name | Type | Description |
|---|---|---|
| SB424323 | DRUG | - |
Inclusion Criteria: * Patients with non valvular atrial fibrillation and any of the following: * \</= 60 years old with no heart disease. * 60 years old with heart disease but no risk factors. * \>/=60 years old and \</=75 years old with no risk factors and no heart disease. * Must be able to take ...